November 7, 2023

Biomia co-founders publish in Nature Chemical Biology

Biomia ApS, a synthetic biology company enabling discovery, development, and manufacturing of plant-inspired natural and new-to-nature small molecule medicines, publish novel drug candidates in the journal Nature Chemical Biology.
Read more
September 26, 2023

Biomia Secures $3.0 Million in Pre-seed Financing

Biomia Secures $3.0 Million in pre-seed financing to accelerate development of its pipeline of plant-inspired natural and new-to-nature halogenated small molecule drug candidates as well as its fermentation-based manufacturing platform and drug discovery engine.
Read more
August 31, 2022

Pioneering Biomia Research Published in Nature

Biomia published the first-in-class whole-cell manufacturing of the natural plant-derived cancer chemotherapeutic agent vinblastine (Velban™) in the journal Nature exemplifying the longest ever engineered whole-cell assembly line.
Read more